REQUEST A DEMO
Total
USD $0.00
Search more companies

Taiho Pharma Asia Pacific Pte. Ltd. (Singapore)

Main Activities: Wholesale Trade
Secondary Activities: Corporate, Subsidiary, and Regional Managing Offices
Full name: Taiho Pharma Asia Pacific Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Taiho Pharma Asia Pacific Pte. Ltd. is based in Singapore. The head office is in Singapore. The company operates in the Wholesale Trade sector. It was incorporated on July 19, 2011. It currently has a total number of 30 (estimated) employees. From the latest financial highlights, Taiho Pharma Asia Pacific Pte. Ltd. reported a net sales revenue increase of 28.1% in 2024. A growth of 59.1% was recorded in its total assets. In, 2024, the company’s net profit margin increased by 2.35%.

Headquarters
1 Kim Seng Promenade #14-09 Great World City Singapore
Singapore; Singapore; Postal Code: 237994

Contact Details: Purchase the Taiho Pharma Asia Pacific Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Taiho Pharma Asia Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Taiho Pharma Asia Pacific Pte. Ltd. report to view the information.
Incorporation Date:
July 19, 2011
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
63.49%
Company Performance
Financial values in the chart are available after Taiho Pharma Asia Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
28.1%
Total Operating Revenue
28.1%
Net Profit/Loss for the Period
219.83%
Total Assets
59.1%
Total Equity
73.81%
Net Profit Margin
2.35%
Return on Equity (ROE)
4.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?